News & Events

C-Path and Cure Mito Announce Data Sharing Agreement to Support Treatment Development For Leigh Syndrome and Mitochondrial Disease

TUCSON, Ariz., November 9, 2021 — Critical Path Institute (C-Path) and Cure Mito Foundation (Cure Mito) today announced a joint collaboration to significantly promote data sharing and accelerate Leigh syndrome and other rare mitochondrial disease data incorporation into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®). Leigh syndrome, also known as Leigh disease, is […]

Academic Innovation Leader and Experienced Scientist to Join C-Path’s PKD Consortium

Sorin Fedeles, Ph.D., MBA to serve as new Executive Director TUCSON, Ariz., October 14, 2021 – Critical Path Institute (C-Path) today announced it has named Sorin Fedeles, Ph.D., MBA as Executive Director of its Polycystic Kidney Disease Outcomes Consortium (PKDOC), effective October 1, 2021. Dr. Fedeles comes to C-Path after 12-plus years as a scientist […]

C-Path Appoints Tufts’ Jonathan M. Davis as Senior Advisor in Pediatrics

TUCSON, Ariz., September 16, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jonathan M. Davis, M.D., as Senior Advisor in Pediatrics working with its International Neonatal Consortium (INC) and advising on drug and device development in infants and children, effective immediately. Davis is Vice-Chair of Pediatrics and Chief of Newborn Medicine at […]

Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program

C-Path, NORD and FDA host annual meeting, demonstration and launch of new rare disease data and analytics platform. TUCSON, Ariz. and WASHINGTON, September 15, 2021 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) officially launched its next phase on Tuesday establishing itself as the leading platform to accelerate rare disease treatment innovation. […]